Romidepsin strongly inhibits HDAC1 and HDAC2 with IC5N/A of 1.6 nM and 3.9 nM, respectively, but is relatively weak in inhibiting HDAC4 and HDAC6 with IC5N/A 25 nM and 79N/A nM, respectively.
More Information Supplier PageRomidepsin strongly inhibits HDAC1 and HDAC2 with IC5N/A of 1.6 nM and 3.9 nM, respectively, but is relatively weak in inhibiting HDAC4 and HDAC6 with IC5N/A 25 nM and 79N/A nM, respectively.
More Information Supplier PageReboxetine mesylate is a potent and selective inhibitor of SLC6A2 noradrenalin uptake (Ki values are 1.1, 129 and > 1N/A,N/AN/AN/A nM for rat SLC6A2, ST, and DAT, respectively).
More Information Supplier PageReboxetine mesylate is a potent and selective inhibitor of SLC6A2 noradrenalin uptake (Ki values are 1.1, 129 and > 1N/A,N/AN/AN/A nM for rat SLC6A2, ST, and DAT, respectively).
More Information Supplier PageReboxetine mesylate is a potent and selective inhibitor of SLC6A2 noradrenalin uptake (Ki values are 1.1, 129 and > 1N/A,N/AN/AN/A nM for rat SLC6A2, ST, and DAT, respectively).
More Information Supplier PageReboxetine mesylate is a potent and selective inhibitor of SLC6A2 noradrenalin uptake (Ki values are 1.1, 129 and > 1N/A,N/AN/AN/A nM for rat SLC6A2, ST, and DAT, respectively).
More Information Supplier PageReboxetine mesylate is a potent and selective inhibitor of SLC6A2 noradrenalin uptake (Ki values are 1.1, 129 and > 1N/A,N/AN/AN/A nM for rat SLC6A2, ST, and DAT, respectively).
More Information Supplier Page
